Keyword: Moderna


J&J Ends Mosaico HIV Vaccine Trial on poor Results

27.01.2023 -

Johnson & Johnson’s pharmaceuticals subsidiary Janssen is walking away from plans to launch an HIV vaccine in the immediate future after the data safety monitoring board...


Moderna Buys Japan’s OriCiro Genomics

06.01.2023 -

In its first acquisition since forming in 2010, mRNA specialist Moderna is buying Japan’s OriCiro Genomics for $85 million, expanding its therapeutics and vaccines...


Pfizer Files Rebuttal of Moderna’s Patent Claim

08.12.2022 -

Faced with a lawsuit from US rival Moderna, alleging that Pfizer and its German partner BioNTech infringed one of its patent for their top-selling Covid-19 vaccine...


Omicron-targeted Covid Boosters may not be Better

28.10.2022 -

The newly launched bivalent mRNA-based Covid-19 booster shots from Moderna and Pfizer/BioNTech did not show a major improvement over the companies’ first-generation...


Merck & Co and Moderna Proceed with Cancer Vaccine

18.10.2022 -

US drugmaker Merck & Co is going ahead with plans to develop a therapeutic cancer vaccine called mRNA-4157 together with Covid vaccine maker Moderna. This fulfills an...


FDA Grants EUAs to Omicron-targeted Covid Shots

02.09.2022 -

As had been widely expected, the US Food and Drug Administration (FDA) on Aug. 31 granted emergency use authorizations (EUAs) to the new Covid-19 shots developed by mRNA...


Moderna Says Pfizer and BioNTech Infringed Vaccine Patent

30.08.2022 -

BioNTech and Pfizer are facing another lawsuit claiming that their Comirnaty-branded Covid-19 vaccine infringes another company’s patent. The latest to sue is US rival...

Research & Innovation

New Covid Shots Score Points against Omicron

27.06.2022 -

Sanofi and GSK are touting their latecomer protein-based Covid-19 vaccine as a potential game changer in the fight against the Omicron variant.